The estimated Net Worth of Adam Morgan is at least $12.6 Million dollars as of 21 July 2023. Adam Morgan owns over 2,486,744 units of Heron Therapeutics Inc stock worth over $12,646,007 and over the last 2 years Adam sold HRTX stock worth over $0.
Adam has made over 2 trades of the Heron Therapeutics Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Adam bought 2,486,744 units of HRTX stock worth $3,406,839 on 21 July 2023.
The largest trade Adam's ever made was buying 2,486,744 units of Heron Therapeutics Inc stock on 21 July 2023 worth over $3,406,839. On average, Adam trades about 777,729 units every 13 days since 2023. As of 21 July 2023 Adam still owns at least 6,986,744 units of Heron Therapeutics Inc stock.
You can see the complete history of Adam Morgan stock trades at the bottom of the page.
Adam's mailing address filed with the SEC is 4242 CAMPUS POINT COURT, SUITE 200, , SAN DIEGO, CA, 92121.
Over the last 11 years, insiders at Heron Therapeutics Inc have traded over $96,663,574 worth of Heron Therapeutics Inc stock and bought 6,549,746 units worth $56,275,132 . The most active insiders traders include Kevin Ctang Capital Managem..., Adam Morgan und Craig A Collard. On average, Heron Therapeutics Inc executives and independent directors trade stock every 30 days with the average trade being worth of $176,989. The most recent stock trade was executed by Craig A Collard on 19 July 2024, trading 13,797 units of HRTX stock currently worth $24,973.
heron therapeutics, inc. (formerly a.p. pharma, inc.) is a specialty pharmaceutical company developing products using its proprietary biochronomer™ polymer-based drug delivery platform. this drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
Heron Therapeutics Inc executives and other stock owners filed with the SEC include: